Library Process-optimization-for-mAb-commercial-manufacturing 
ISPE
OCTOBER 27, 2022
Cell and gene therapies (C>) have unique needs in manufacturing suites that differ from those for classic product biopharmaceuticals. C sponsors currently address numerous emerging pharmaceutical entities, as well as manufacturing platforms, modes, and scale. These considerations include processing safety (e.g.,
ISPE
MARCH 15, 2023
In facility design, solutions are derived through science-based analyses of environmental impacts from the materials, processes, services, and architecture. linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). 7 An integrative (vs. 7 An integrative (vs.
Expert insights. Personalized for you.
52 
Let's personalize your content